Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

HbO2 Therapeutics

HbO2 Therapeutics
2014 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Angel LATEST DEAL TYPE
$2.75M LATEST DEAL AMOUNT
Description

Developer of hemoglobin based technologies. The company provides intravenous oxygen-delivery support to help stabilize the patient and prevent tissue damage or organ dysfunction associated with oxygen deprivation.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Other Healthcare
Primary Office
  • 674 Souder Road
  • Souderton, PA 18964
  • United States

+1 (267) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore HbO2 Therapeutics’s full profile, request a free trial.

HbO2 Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Angel (individual) 13-Apr-2015 $2.75M 00.00 Completed Startup
1. Angel (individual) 13-Mar-2015 00.000 00.000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

HbO2 Therapeutics Executive Team (3)

Name Title Board
Seat
Contact
Info
Gerald Kowalski Co-Founder and Chairman
Zafiris Zafirelis Co-Founder, President and Chief Executive Officer
Igor Serov Chief Financial Officer

HbO2 Therapeutics Board Members (1)

Name Representing Role Since Contact
Info
Gerald Kowalski HbO2 Therapeutics Co-Founder and Chairman 000 0000